Clinical Trial

Trial Protocol ID BGB-11417-201

Trial Description

A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of
Bcl-2 Inhibitor BGB-11417 in Patients With Relapsed or Refractory Mantle Cell Lymphoma

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, M.D.

Disease Types

Sponsor

  • BeiGene USA Inc.

ClinicalTrials.gov NCT ID

  • NCT05471843